Stay updated on Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T00:00:32.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Page revision updated to v3.4.3; previous revision v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-11T18:43:04.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    Fallopian Tube Cancer is now listed among the study's conditions, expanding the scope of eligible diseases. This clarifies the target patient population and improves searchability and eligibility assessment.
    Difference
    0.0%
    Check dated 2026-02-18T05:00:28.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Primary Peritoneal Carcinoma was added to the conditions list and the Genetic and Rare Diseases Information Center resource was added to Resources, with a v3.4.2 revision noted. The government funding status notice and prior revision notice (v3.4.1) were removed.
    Difference
    0.5%
    Check dated 2026-02-11T02:53:46.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The changes introduce a site-wide notice about potential data delays due to a lapse in government funding and a version update from v3.4.0 to v3.4.1. These changes do not affect the study content or results; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T00:56:47.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    Added a glossary display and updated footer labels to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-27T23:57:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial page.